US Senator moves to end China's normal trade status, hike tariffs
Synopsis
Key Takeaways
US Senator Tammy Baldwin has introduced legislation to revoke China's Permanent Normal Trade Relations (PNTR) status, a move that would trigger significantly higher tariffs on Chinese goods one year after enactment. The Wisconsin Democrat unveiled the bill — the Ending China's Special Treatment Act — as President Donald Trump prepares to meet Chinese President Xi Jinping, adding a fresh legislative dimension to the already fraught US-China trade relationship.
What the Legislation Proposes
Under Baldwin's proposal, Chinese imports would be moved to the tariff rates listed in Column 2 of the US Harmonised Tariff Schedule — rates that are generally higher than those currently applicable to China and vary by product. Crucially, the bill does not impose a single uniform tariff across all Chinese goods; the impact would differ sector by sector.
The measure would also require the US Trade Representative to prepare a comprehensive report on continuing trade and economic challenges posed by China, developed in consultation with the Commerce Department, the US International Trade Commission, and the US-China Economic and Security Review Commission. That report would inform future policy decisions, according to Baldwin's office.
Baldwin's Case Against Beijing — and Trump
'We need a trade system that puts American workers, companies, and families first,' Baldwin said in a statement announcing the bill. She accused Beijing of market manipulation, intellectual property theft, and policies that she argues undermine American manufacturers.
Notably, Baldwin also trained her criticism on the Trump administration itself, arguing that the White House's shifting trade measures had increased uncertainty and costs without delivering manufacturing jobs back to the United States. By anchoring China's tariff treatment in statute rather than executive action, her proposal aims to insulate policy from the legal challenges and reversals that have dogged past presidential trade moves.
Background: PNTR and the 2024 Commission Report
China's PNTR status — which grants it the same trade terms extended to US allies — has been contested for years. The US-China Economic and Security Review Commission formally recommended in its 2024 annual report that Congress repeal the arrangement, arguing it allowed China to benefit from preferential terms despite practices the commission described as intellectual property theft and market manipulation. That recommendation was advisory and carried no binding force.
Separately, the US International Trade Commission launched an investigation in February to examine the consequences of applying Column 2 duties to Chinese products over a six-year horizon, covering effects on US production, prices, trade flows, and sourcing. The investigation's findings are expected to shape any eventual legislative or executive response.
What It Means in Practice
Baldwin's bill is a legislative proposal and does not, by itself, alter the tariffs importers currently pay. It would need to pass both chambers of Congress and be signed into law before the one-year countdown to PNTR withdrawal could begin. The absence of a product-by-product tariff assessment in the announcement means the full economic impact remains unquantified at this stage. This comes amid broader uncertainty over US trade policy, with the Trump administration's executive tariff actions already facing legal scrutiny in domestic courts.
What Happens Next
The bill's trajectory in Congress will be closely watched, particularly against the backdrop of a potential Trump-Xi summit. Any diplomatic progress between Washington and Beijing could affect the legislative appetite for a measure as sweeping as stripping China of its PNTR status. Industry groups and trade economists are expected to weigh in as the US International Trade Commission's investigation matures.